Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. [electronic resource]
Producer: 20010322Description: 3878-84 p. digitalISSN:- 1078-0432
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Brain Neoplasms -- drug therapy
- Cisplatin -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Eflornithine -- administration & dosage
- Female
- Glioblastoma -- drug therapy
- Humans
- Lomustine -- administration & dosage
- Male
- Middle Aged
- Procarbazine -- administration & dosage
- Prospective Studies
- Time Factors
- Vincristine -- administration & dosage
- Vindesine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.